O-GlcNAc and the control of gene expression

Biochimica et Biophysica Acta - General Subjects

Volumn 1473, Issue 1, 1999, Pages 161-171

  Comer, Frank I ^a   Hart, Gerald W ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

N Acetylglucosamine; O Linked N acetylglucosamine; Protein glycosylation; Transcription

Indexed keywords

ESTROGEN RECEPTOR; N ACETYLGLUCOSAMINE; PROTEIN P53; RNA POLYMERASE II; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1;

GENE EXPRESSION REGULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; TRANSLATION REGULATION;

ACETYLGLUCOSAMINE; CHROMATIN; EUKARYOTIC CELLS; GENE EXPRESSION REGULATION; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA POLYMERASE II; TRANSCRIPTION FACTORS;

EUKARYOTA;

EID: 0032734974     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(99)00176-2     Document Type: Review

References (56)

1. Torres C.-R., Hart G.W. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. J. Biol. Chem. 259:1984;3308-3317.
2. Hart G.W. Dynamic O-glycosylation of nuclear and cytoskeletal proteins. Annu. Rev. Biochem. 66:1997;315-335.
3. L.K. Kreppel and G.W. Hart, Functional Significance of O-GlcNAc glycoproteins in the nucleus and cytoplasm, in: M. Fukuda and O. Hindsgaul (Eds.), Molecular and Cellular Glycobiology: Frontiers in Molecular Biology. Oxford University Press, Oxford (submitted).
4. Snow D.M., Hart G.W. Nuclear and cytoplasmic glycosylation. Int. Rev. Cytol. 181:1998;43-74.
5. Kelly W.G., Dahmus M.E., Hart G.W. RNA polymerase II is a glycoprotein: modification of the C-terminal domain by O-GlcNAc. J. Biol. Chem. 268:1993;10416-10424.
6. Ku N.-O., Omary M.B. Expression, glycosylation, and phosphorylation of human keratins 8 18 in insect cells. Exp. Cell. Res. 211:1994;24-35.
7. Chou T.-Y., Hart G.W., Dang C.V. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270:1995;18961-18965.
8. Haltiwanger R.S., Blomberg M.A., Hart G.W. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosaminepolypeptide β-N-acetylglucosaminyltransferase. J. Biol. Chem. 267:1992;9005-9013.
9. Kreppel L.K., Hart G.W. Cloning and characterization of O-GlcNAc transferase: A novel highly conserved enzyme. FASEB J. 10:1996;A1120.
10. Lubas W.A., Frank D.W., Krause M., Hanover J.A. O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J. Biol. Chem. 272:1997;9316-9324.
11. Dong D.L., Hart G.W. Purification and characterization of an O-GlcNAc selective N-acetyl-β-D-glucosaminidase from rat spleen cytosol. J. Biol. Chem. 269:1994;19321-19330.
12. Kearse K.P., Hart G.W. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc. Natl. Acad. Sci. USA. 88:1991;1701-1705.
13. Kelly W.G., Hart G.W. Glycosylation of chromosomal proteins: localization of O-linked N-acetylglucosamine in Drosophila chromatin. Cell. 57:1989;243-251.
14. W.G. Kelly and G.W. Hart, Carbohydrate modification of chromosomal proteins: Evidence for O-GlcNAc addition, J. Cell. Biol., 1988 (in press).
15. Davie J.R. Covalent modifications of histones: expression from chromatin templates. Curr. Opin. Genet. Dev. 8:1998;173-178.
16. Kadonaga J.T. Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell. 92:1998;307-313.
17. Jackson S.P., Tjian R. O-Glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation. Cell. 55:1988;125-133.
18. Han I., Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome suseptibility. Mol. Cell. Biol. 17:1997;2550-2558.
19. Roos M.D.K.S., Baker J.R., Kudlow J.E. O Glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol. Cell. Biol. 17:1997;6472-6480.
20. Schaufele B.W.F., Reudelhuber T.L. Overlapping Pit-1 and Sp1 binding sites are both essential to full rat growth hormone gene promoter activity despite mutually exclusive Pit-1 and Sp1 binding. J. Biol. Chem. 265:1990;17189-17196.
21. Fanning E., Knippers R. Structure and function of simian virus 40 large tumor antigen. Annu. Rev. Biochem. 61:1992;55-85.
22. Schmidt-Ullrich R., Thompson W.S., Wallach D.F. Biochemical and immunochemical characterization of two simian virus 40 (SV40)-specific glycoproteins in nuclear and surface membranes of SV40-transformed cells. Biochem. Biophys. Res. Commun. 88:1979;887-894.
23. Medina L., Grove K., Haltiwanger R.S. SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation. Glycobiology. 8:1998;383-391.
24. Courtois G., Morgan J.G., Campbell L.A., Fourel G., Crabtree G.R. Interaction of a liver-specific nuclear factor with the fibrinogen and α 1-antitrypsin promoters. Science. 238:1987;688-692.
25. Lichtsteiner S., Schibler U. A glycosylated liver-specific transcription factor stimulates transcription of the albumin gene. Cell. 57:1989;1179-1187.
26. Friend S. p53: a glimpse at the puppet behind the shadow play. Science. 265:1994;334-335.
27. Shaw P., Freeman J., Bovey R., Iggo R. Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. Oncogene. 12:1996;921-930.
28. Chou T.Y., Dang C.V., Hart G.W. Glycosylation of the C-Myc transactivation domain. Proc. Natl. Acad. Sci. USA. 92:1995;4417-4421.
29. Amati B., Dalton S., Brooks M.W., Littlewood T.D., Evan G.I., Land H. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature. 359:1992;423-426.
30. Hoang A.T., Lutterbach B., Lewis B.C., Yano T., Chou T.-Y., Barrett J.F., Raffeld M., Hann S.R., Dang C.V. A link between increased transforming activity of lymphoma-derived MYC mutant allels, their defective regulation by p107, and altered phophorylation of the c-Myc transactivation domain. Mol. Cell. Biol. 15:1995;4031-4042.
31. Privalsky M.L. A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated. J. Virol. 64:1990;463-466.
32. Tzagarakis-Foster C., Privalsky M.L. Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding. J. Biol. Chem. 273:1998;10926-10932.
33. Reason A.J., Morris H.R., Panico M., Marais R., Treisman R.H., Haltiwanger R.S., Hart G.W., Kelly W.G., Dell A. Localization of O-GlcNAc modification on the serum response transcription factor. J. Biol. Chem. 267:1992;16911-16921.
34. Treisman R. The serum response element. Trends Biochem. Sci. 17:1992;423-426.
35. Jiang M.-S., Hart G.W. A subpopulation of estrogen receptors are modified by O-linked N-acetylglucosamine. J. Biol. Chem. 272:1997;2421-2428.
36. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21:1996;267-271.
37. Hampsey M. Molecular genetics of the RNA polymerase II general transcriptional machinery. Microbiol. Mol. Biol. Rev. 62:1998;465-503.
38. Dahmus M.E. Phosphorylation of the C-terminal domain of RNA polymerase II. Biochim. Biophys. Acta. 1261:1995;171-182.
39. Corden J.L. Tails of RNA polymerase II. Trends Biochem. Sci. 15:1990;383-387.
40. Shilatifard A. The RNA polymerase II general elongation complex. Biol. Chem. 379:1998;27-31.
41. Steinmetz E.J. Pre-mRNA processing and the CTD of RNA polymerase II: the tail that wags the dog? Cell. 89:1997;491-494.
42. Holt G.D., Hart G.W. The subcellular distribution of terminal N-acetylglucosamine moieties: localization of a novel protein-saccharide linkage O-linked GlcNAc. J. Biol. Chem. 261:1986;8049-8057.
43. Holt G.D., Snow C.M., Senior A., Haltiwanger R.S., Gerace L., Hart G.W. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J. Cell. Biol. 104:1987;1157-1164.
44. Hanover J.A. The nuclear pore: at the crossroads. FASEB J. 6:1992;2288-2295.
45. Finlay D.R., Newmeyer D.D., Price T.M., Forbes D.J. Inhibition of in vitro nuclear transport by a lectin that binds to nuclear pores. J. Cell. Biol. 104:1987;189-200.
46. Finlay D.R., Forbes D.J. Reconstitution of biochemically altered nuclear pores: transport can be eliminated and restored. Cell. 60:1990;17-29.
47. Featherstone C., Darby M.K., Gerace L. A monoclonal antibody against the nuclear pore complex inhibits nucleocytoplasmic transport of protein and RNA in vivo. J. Cell. Biol. 107:1988;1289-1297.
48. Goldfarb D., Michaud N. Pathways for the nuclear transport of proteins and RNA's. Trends Cell Biol. 1:1991;20-24.
49. Pain V.M. Initiation of protein synthesis in eukaryotic cells. Eur. J. Biochem. 236:1996;747-771.
50. Gupta N.K. Mammalian peptide chain initiation: thirty years of research. Int. J. Biochem. Biophys. 33:1996;239-252.
51. Datta B., Chakrabarti D., Roy A.L., Gupta N.K. Roles of a 67-kDa polypeptide in reversal of protein synthesis inhibition in heme-deficient reticulocyte lysate. Proc. Natl. Acad. Sci. USA. 85:1988;3324-3328.
52. Datta B., Ray M.K., Chakrabarti D., Wylie D.E., Gupta N.K. Glycosylation of eukaryotic peptide chain initiation factor 2 (eIF-2)-associated 67-kDa polypeptide (p67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2 α-subunit. J. Biol. Chem. 264:1989;20620-20624.
53. 67) plays a critical role in regulation of protein synthesis initiation in animal cells. Proc. Natl. Acad. Sci. USA. 89:1992;539-543.
54. Chakraborty A., Saha D., Bose A., Chatterjee M., Gupta N.K. Regulation of eIF-2 α-subunit phosphorylation in reticulocyte lysate. Biochemistry. 33:1994;6700-6706.
55. Holstege F.C.P., Young R.A. Transcriptional regulation: Contending with complexity. Proc. Natl. Acad. Sci. USA. 96:1999;2-4.
56. Greis K.D., Hayes B.K., Comer F.I., Kirk M., Barnes S., Lowary T.L., Hart G.W. Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by β-elimination and tandem electrospray mass spectrometry. Anal. Biochem. 234:1996;38-49.